Literature DB >> 9571335

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

M I Harris1, K M Flegal, C C Cowie, M S Eberhardt, D E Goldstein, R R Little, H M Wiedmeyer, D D Byrd-Holt.   

Abstract

OBJECTIVE: To evaluate the prevalence and time trends for diagnosed and undiagnosed diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults by age, sex, and race or ethnic group, based on data from the Third National Health and Nutrition Examination Survey, 1988-1994 (NHANES III) and prior Health and Nutrition Examination Surveys (HANESs). RESEARCH DESIGN AND METHODS: NHANES III contained a probability sample of 18,825 U.S. adults > or = 20 years of age who were interviewed to ascertain a medical history of diagnosed diabetes, a subsample of 6,587 adults for whom fasting plasma glucose values were obtained, and a subsample of 2,844 adults between 40 and 74 years of age who received an oral glucose tolerance test. The Second National Health and Nutrition Examination Survey, 1976-1980, and Hispanic HANES used similar procedures to ascertain diabetes. Prevalence was calculated using the 1997 American Diabetes Association fasting plasma glucose criteria and the 1980-1985 World Health Organization (WHO) oral glucose tolerance test criteria.
RESULTS: Prevalence of diagnosed diabetes in 1988-1994 was estimated to be 5.1% for U.S. adults > or = 20 years of age (10.2 million people when extrapolated to the 1997 U.S. population). Using American Diabetes Association criteria, the prevalence of undiagnosed diabetes (fasting plasma glucose > or = 126 mg/dl) was 2.7% (5.4 million), and the prevalence of impaired fasting glucose (110 to < 126 mg/dl) was 6.9% (13.4 million). There were similar rates of diabetes for men and women, but the rates for non-Hispanic blacks and Mexican-Americans were 1.6 and 1.9 times the rate for non-Hispanic whites. Based on American Diabetes Association criteria, prevalence of diabetes (diagnosed plus undiagnosed) in the total population of people who were 40-74 years of age increased from 8.9% in the period 1976-1980 to 12.3% by 1988-1994. A similar increase was found when WHO criteria were applied (11.4 and 14.3%).
CONCLUSIONS: The high rates of abnormal fasting and postchallenge glucose found in NHANES III, together with the increasing frequency of obesity and sedentary lifestyles in the population, make it likely that diabetes will continue to be a major health problem in the U.S.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9571335     DOI: 10.2337/diacare.21.4.518

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  526 in total

Review 1.  Clinical evidence: glycaemic control in diabetes.

Authors:  W H Herman
Journal:  BMJ       Date:  1999-07-10

2.  Preventive medicine in people at high risk for chronic disease: the value of identifying and treating diabetes.

Authors:  H C Gerstein; S Meltzer
Journal:  CMAJ       Date:  1999-06-01       Impact factor: 8.262

3.  Dilution of the 75-g oral glucose tolerance test increases postprandial glycemia: implications for diagnostic criteria.

Authors:  J L Sievenpiper; D J Jenkins; R G Josse; V Vuksan
Journal:  CMAJ       Date:  2000-04-04       Impact factor: 8.262

4.  Revisiting the oral glucose tolerance test criterion for the diagnosis of diabetes.

Authors:  M B Davidson; D L Schriger; A L Peters; B Lorber
Journal:  J Gen Intern Med       Date:  2000-08       Impact factor: 5.128

5.  Turning down insulin signaling.

Authors:  M J Birnbaum
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

6.  NAFLD and insulin resistance do not increase the risk of postoperative complications among patients undergoing bariatric surgery--a prospective analysis.

Authors:  Tarsila Ribeireiro; James Swain; Michael Sarr; Michael Kendrick; Florencia Que; Schuyler Sanderson; Anuradha Krishnan; Kimberly Viker; Kymberly Watt; Michael Charlton
Journal:  Obes Surg       Date:  2011-03       Impact factor: 4.129

7.  Excess type 2 diabetes in African-American women and men aged 40-74 and socioeconomic status: evidence from the Third National Health and Nutrition Examination Survey.

Authors:  J M Robbins; V Vaccarino; H Zhang; S V Kasl
Journal:  J Epidemiol Community Health       Date:  2000-11       Impact factor: 3.710

8.  Altered expression of hepatic β-adrenergic receptors in aging rats: implications for age-related metabolic dysfunction in liver.

Authors:  Yun Shi; Zhen-Ju Shu; Hanzhou Wang; Jeffrey L Barnes; Chih-Ko Yeh; Paramita M Ghosh; Michael S Katz; Amrita Kamat
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-12-06       Impact factor: 3.619

9.  Ethnic and gender susceptibility to metabolic risk.

Authors:  Scott M Grundy; Ian J Neeland; Aslan T Turer; Gloria Lena Vega
Journal:  Metab Syndr Relat Disord       Date:  2013-12-10       Impact factor: 1.894

Review 10.  Type 2 diabetes and risk of cognitive impairment and dementia.

Authors:  Rachel A Whitmer
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.